Skip to content
2000
Volume 23, Issue 14
  • ISSN: 1871-5206
  • E-ISSN: 1875-5992

Abstract

Background/Introduction: 4-aryl-4H-chromenes have attracted attention as potential anticancer agents. Objective: In an effort to discover effective compounds, we designed a new series of these chromenes with methoxy substitution at 2, 3, 4, 5, and 6 positions. Methods: The synthesized compounds were tested for anticancer properties against two human cancer cell lines (MCF- 7 and PC3) as well as a normal cell line. Furthermore, induction of apoptosis was explored through various methods, such as flow cytometry analysis, morphological changes, activation of caspase 3, ROS, and MMP. Results: The MTT assay showed that the 5g derivative, with methoxy groups at and positions, exhibited the highest potency (IC = 40 μM) against the PC3 cell line. Our findings revealed that compound 5g induced apoptosis in the PC3 cell line, which was demonstrated by activation of caspase 3, an increase in ROS levels, and early apoptosis percentage. Conclusion: These results suggest that compound 5g holds promise as a potential therapeutic approach to cancer treatment.

Loading

Article metrics loading...

/content/journals/acamc/10.2174/1871520623666230504101651
2023-08-01
2025-07-14
Loading full text...

Full text loading...

/content/journals/acamc/10.2174/1871520623666230504101651
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test